Literature DB >> 16927613

Fade to black: importation and counterfeit drugs.

Bryan A Liang1.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16927613     DOI： 10.1177/009885880603200207

Source DB:  PubMed          Journal:  Am J Law Med        ISSN： 0098-8588


× No keyword cloud information.
  11 in total

Review 1.  The health and economic effects of counterfeit drugs.

Authors:  Erwin A Blackstone; Joseph P Fuhr; Steve Pociask
Journal:  Am Health Drug Benefits       Date:  2014-06

2.  Small molecules showing significant protection of mice against botulinum neurotoxin serotype A.

Authors:  Yuan-Ping Pang; Jon Davis; Shaohua Wang; Jewn Giew Park; Madhusoodana P Nambiar; James J Schmidt; Charles B Millard
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

3.  Estimating the Effect of Health Insurance on Personal Prescription Drug Importation.

Authors:  Andrew R Zullo; Chanelle J Howe; Omar Galárraga
Journal:  Med Care Res Rev       Date:  2016-08-03       Impact factor: 3.929

4.  Are drug companies living up to their human rights responsibilities? Moving toward assessment.

Authors:  Sofia Gruskin; Zyde Raad
Journal:  PLoS Med       Date:  2010-09-28       Impact factor: 11.069

5.  Online availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics.

Authors:  Bryan A Liang; Tim K Mackey
Journal:  J Med Internet Res       Date:  2012-02-09       Impact factor: 5.428

6.  Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.

Authors:  Tim K Mackey; Bryan A Liang; Peter York; Thomas Kubic
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

7.  Substandard and counterfeit medicines: a systematic review of the literature.

Authors:  Tariq Almuzaini; Imti Choonara; Helen Sammons
Journal:  BMJ Open       Date:  2013-08-17       Impact factor: 2.692

Review 8.  Interventions to combat or prevent drug counterfeiting: a systematic review.

Authors:  Fadi El-Jardali; Elie A Akl; Racha Fadlallah; Sandy Oliver; Nadine Saleh; Lamya El-Bawab; Rana Rizk; Aida Farha; Rasha Hamra
Journal:  BMJ Open       Date:  2015-03-18       Impact factor: 2.692

9.  Combating healthcare corruption and fraud with improved global health governance.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  BMC Int Health Hum Rights       Date:  2012-10-22

10.  Microbiological contamination in counterfeit and unapproved drugs.

Authors:  Dieter Pullirsch; Julie Bellemare; Andreas Hackl; Yvon-Louis Trottier; Andreas Mayrhofer; Heidemarie Schindl; Christine Taillon; Christian Gartner; Brigitte Hottowy; Gerhard Beck; Jacques Gagnon
Journal:  BMC Pharmacol Toxicol       Date:  2014-06-26       Impact factor: 2.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.